Strategies targeting the EGFR may well have a therapeutic potential in bladder cancer, since the receptor is frequently expressed at high levels in this disease and patients with tumours expressing high levels of EGFR tend to have a poor prognosis (Mellon et al, 1995). Here, EGFR is linked to urinary bladder cancer.